Linked Data API

Show Search Form

Search Results

1697887
registered interest false more like this
date less than 2024-03-21more like thismore than 2024-03-21
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Attention Deficit Hyperactivity Disorder: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps her Department is taking to give patients access to information on stock levels of ADHD medication at high street pharmacies; and whether her Department has made an assessment of the potential merits of giving patients access to the Medicines Supply Tool. more like this
tabling member constituency Dulwich and West Norwood remove filter
tabling member printed
Helen Hayes more like this
uin 19915 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-26more like thismore than 2024-03-26
answer text <p>There were 10,558 community pharmacies in England on 29 February 2024, including 405 distance selling pharmacies. These contractors are independent private businesses contracted to provide services within the National Health Service. While the Department does not monitor their stock levels, it does have a role in managing supply at a national level to help ensure stocks are available from manufacturers to meet demand from patients across the country. We are often made aware of supply issues. Thankfully the vast majority can be managed with no impact to patients.</p><p>We work with the industry, the NHS, the Medicines and Healthcare products Regulatory Agency and others working across the supply chain to manage issues and we provide guidance for health care professionals about medicines that are experiencing supply issues on how to manage patients during a disruption where necessary.</p><p>The Medicine Supply Tool is designed to provide information and guidance for healthcare professionals, rather than members of the public. However, a public-facing page on attention deficit hyperactivity disorder medicine supply is available at the following link:</p><p><a href="https://www.sps.nhs.uk/articles/prescribing-available-medicines-to-treat-adhd/" target="_blank">https://www.sps.nhs.uk/articles/prescribing-available-medicines-to-treat-adhd/</a></p><p>Any patient who is worried about the supply of their medication should speak to their clinician, in the first instance.</p>
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
grouped question UIN 19916 more like this
question first answered
less than 2024-03-26T15:22:10.277Zmore like thismore than 2024-03-26T15:22:10.277Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4510
label Biography information for Helen Hayes more like this
1692173
registered interest false more like this
date less than 2024-02-27more like thisremove minimum value filter
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Estradiol more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of the supply of Estradot patches for women with menopausal symptoms. more like this
tabling member constituency Dulwich and West Norwood remove filter
tabling member printed
Helen Hayes more like this
uin 15964 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-06more like thismore than 2024-03-06
answer text <p>There are over 70 hormone replacement therapy (HRT) products licensed for supply in the United Kingdom. There have been issues with the supply of a limited number of HRT products, primarily due to very sharp increases in demand, but the supply position has improved considerably over the last year, following intensive work with industry. We have held roundtables, and continue to do so, with suppliers, wholesalers, and community pharmacists to discuss the challenges they are facing, and what needs to be done to address them.</p><p>Intermittent supply issues were affecting estradot patches, which resulted in the use of a Serious Shortage Protocol, to allow pharmacists to supply an alternative brand of estradiol patches where estradot patches were not available. However, the issues have now been resolved and supplies should be available. We are continuing to engage closely with the supplier to monitor the supply position and drive action.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
grouped question UIN 15965 more like this
question first answered
less than 2024-03-06T17:16:54.167Zmore like thismore than 2024-03-06T17:16:54.167Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4510
label Biography information for Helen Hayes more like this
1692174
registered interest false more like this
date less than 2024-02-27more like thisremove minimum value filter
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Estradiol more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what steps she is taking to help resolve supply chain issues for Estradot patches; and whether she has made an assessment of the potential impact of the UK’s withdrawal from the EU on such supplies. more like this
tabling member constituency Dulwich and West Norwood remove filter
tabling member printed
Helen Hayes more like this
uin 15965 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-06more like thismore than 2024-03-06
answer text <p>There are over 70 hormone replacement therapy (HRT) products licensed for supply in the United Kingdom. There have been issues with the supply of a limited number of HRT products, primarily due to very sharp increases in demand, but the supply position has improved considerably over the last year, following intensive work with industry. We have held roundtables, and continue to do so, with suppliers, wholesalers, and community pharmacists to discuss the challenges they are facing, and what needs to be done to address them.</p><p>Intermittent supply issues were affecting estradot patches, which resulted in the use of a Serious Shortage Protocol, to allow pharmacists to supply an alternative brand of estradiol patches where estradot patches were not available. However, the issues have now been resolved and supplies should be available. We are continuing to engage closely with the supplier to monitor the supply position and drive action.</p> more like this
answering member constituency Pendle more like this
answering member printed Andrew Stephenson more like this
grouped question UIN 15964 more like this
question first answered
less than 2024-03-06T17:16:54.217Zmore like thismore than 2024-03-06T17:16:54.217Z
answering member
4044
label Biography information for Andrew Stephenson more like this
tabling member
4510
label Biography information for Helen Hayes more like this
1692175
registered interest false more like this
date less than 2024-02-27more like thisremove minimum value filter
answering body
Department of Health and Social Care more like this
answering dept id 17 remove filter
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Menopause: Mental Health Services more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what estimate she has made of the average waiting time for cognitive behavioural therapy for women with menopausal symptoms in London. more like this
tabling member constituency Dulwich and West Norwood remove filter
tabling member printed
Helen Hayes more like this
uin 15966 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-03-05more like thismore than 2024-03-05
answer text <p>Improving care and support for menopause is a priority in the Women’s Health Strategy. It is important that all women experiencing the menopause have access to information and options to enable them to choose the best care to suit them. The National Institute for Health and Care Excellence’s guidelines currently recommend that that cognitive behavioural therapy (CBT) can be recommended for low mood or anxiety that arises as a result of the menopause.</p><p>CBT is offered as part of the NHS Talking Therapies services. The latest data for NHS Talking Therapies in the London region shows that 35,410 females, including trans women, accessed National Health Service funded treatment during the period from October to December 2023. Of these, 91% completing treatment waited less than six weeks for their first appointment, against a target of 75%, and 98% completing treatment waited less than 18 weeks, against a target of 95%. Data is not collected separately for CBT, which is one type of talking therapy. Data is also not collected separately for females with menopausal symptoms. This data is available at the following link:</p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-talking-therapies-monthly-statistics-including-employment-advisors/performance-december-2023-and-quarter-3-2023-24-data" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-talking-therapies-monthly-statistics-including-employment-advisors/performance-december-2023-and-quarter-3-2023-24-data</a></p>
answering member constituency Lewes more like this
answering member printed Maria Caulfield more like this
question first answered
less than 2024-03-05T11:57:12.957Zmore like thismore than 2024-03-05T11:57:12.957Z
answering member
4492
label Biography information for Maria Caulfield more like this
tabling member
4510
label Biography information for Helen Hayes more like this